Author(s):
Manish Patel, Atul Sahu, Anish Chandy
Email(s):
anishpharma@gmail.com
DOI:
10.52711/0975-4377.2026.00008 
Address:
Manish Patel1, Atul Sahu1, Anish Chandy2*
1Students, Pharmaceutics Department, Chouksey School of Pharmacy, CEC, Bilaspur, CG.
2Associate Professor, Pharmaceutics Department, Chouksey School of Pharmacy, CEC, Bilaspur, CG.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2026
ABSTRACT:
A study was conducted on repaglinide, an antihyperglycemic agent, used in the management of non-insulin-dependent diabetes mellitus, to design and characterize bioadhesive buccal films to overcome hepatic first-pass metabolism. The films are prepared using various ratios of bioadhesive polymers like HPMC, chitosan, and carbopol. For elucidating the physicochemical compatibility between the drug and the used polymers, FT-IR spectroscopy was employed. The prepared films were evaluated for in vitro drug release, bioadhesion strength, swelling index, moisture absorption, and surface pH.
Cite this article:
Manish Patel, Atul Sahu, Anish Chandy. Fabrication and Characterization of Novel Repaglinide Incorporated Buccal Film for the Management of Type-2 Diabetes. Research Journal of Pharmaceutical Dosage Forms and Technology.2026; 18(1):47-1. doi: 10.52711/0975-4377.2026.00008
Cite(Electronic):
Manish Patel, Atul Sahu, Anish Chandy. Fabrication and Characterization of Novel Repaglinide Incorporated Buccal Film for the Management of Type-2 Diabetes. Research Journal of Pharmaceutical Dosage Forms and Technology.2026; 18(1):47-1. doi: 10.52711/0975-4377.2026.00008 Available on: https://www.rjpdft.com/AbstractView.aspx?PID=2026-18-1-8
REFERENCES:
1. Choy Fun Wong, Kah Hey Yuen, Kok Khiang Peh., Formulation and Evaluation of controlled release Eudragit buccal patches, International Journal of Pharmaceutics.178;11-22:1999.
2. Gurny R, Meyer JM and Peppas NA. Bioadhesive intraoral release systems: design testing and analysis. Biomaterials, 5; 336-340:1984.
3. Karen Lu Li, Agnes Llamasares Castillo. Formulation and evaluation of a mucoadhesive buccal tablet of mefenamic acid. Braz. J. Pharm. Sci. 2020; 56: e18575
4. Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, Unwin N, Wild SH, Williams R. Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Research and Clinical Practice. 2020 Apr 1; 162:108086.
5. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice. 2017 Jun 1; 128:40-50.
6. Ginter E, Simko V. Global prevalence and future of diabetes mellitus. InDiabetes: An old disease, a new insight 2012 Dec 30 (pp. 35-41). New York, NY: Springer New York.
7. Kumar A, Gangwar R, Ahmad Zargar A, Kumar R, Sharma A. Prevalence of diabetes in India: A review of IDF diabetes atlas 10th edition. Current Diabetes Reviews. 2024 Jan 1;20(1):105-14.
8. Seary H, Barakat EH, Raslan MA, Samy AM. Development, characterization, and optimization of repaglinide loaded spanlastics along with investigation of drug solubility in various media. Universal Journal of Pharmaceutical Research. 2024 Nov 15.
9. Burns C, Francis N. Type 2 Diabetes-etiology, epidemiology, pathogenesis, treatment. In Metabolic Syndrome. Springer, Cham. 2023;1-20.
10. Ke C, Narayan KV, Chan JC, Jha P, Shah BR. Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. Nature Reviews Endocrinology. 2022 Jul; 18(7):413-32.
11. Rao ME, Swain S, Patra CN, Sruti J, Patra S. Development and in vitro evaluation of floating multiparticulate system of repaglinide. FABAD J Pharm Sci. 2011; 36(2):75-92.
12. Augusthy AR, Vipin KV, Chandran SC, Thushara MV, Muhammed ST. Formulation and evaluation of mucoadhesive buccal film of lisinopril. Res Rev J Pharm Nano. 2014 Mar;2(1):45-51.
13. Nafee NA, Boraie MA, Ismail FA, Mortada LM. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharmaceutica (Zagreb, Croatia). 2003 Sep 1; 53(3): 199-212.